Williams E M, Raine A E, Cabrera A A, Whyte J M
Cardiovasc Res. 1975 Sep;9(5):579-92. doi: 10.1093/cvr/9.5.579.
Estimates were made in vivo in rabbits of the relative beta-receptor blocking potency and duration of action of propranolol and practolol. In further experiments groups of litter mates were injected twice daily with approximately equi-active amounts of propranolol or practolol, or with saline, for several weeks. The heart weights of the treated animals were significantly lower than those of the controls, the water contents were higher, and the dry weight differences were highly significant; -16.8% after 2 mg/kg bd propranolol for six weeks and -33.8% after 10 mg/kg practolol. (The treated animals grew less rapidly than the controls; when corrected for body weight these figures were -11.9% and -20.4%, respectively.) In the practolol group, but not the propranolol group, the duration of the atrial intracellular potentials was prolonged. There was no evidence that the prolonged treatment with either drug had a negative inotropic effect, or reduced positive inotropic responses to isoprenaline.
在兔体内对普萘洛尔和美托洛尔的相对β受体阻断效能及作用持续时间进行了评估。在进一步的实验中,将同窝仔兔分组,每日两次注射大约等效活性剂量的普萘洛尔或美托洛尔,或注射生理盐水,持续数周。治疗动物的心脏重量显著低于对照组,含水量更高,干重差异非常显著;6周内每日两次给予2mg/kg普萘洛尔后为-16.8%,每日两次给予10mg/kg美托洛尔后为-33.8%。(治疗动物生长速度比对照组慢;校正体重后,这些数字分别为-11.9%和-20.4%。)在美托洛尔组而非普萘洛尔组中,心房细胞内电位的持续时间延长。没有证据表明两种药物的长期治疗具有负性肌力作用,或降低了对异丙肾上腺素的正性肌力反应。